These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 30360743)
1. Targeting Strategies for Glucose Metabolic Pathways and T Cells in Colorectal Cancer. Wang G; Wang JJ; Guan R; Sun Y; Shi F; Gao J; Fu XL Curr Cancer Drug Targets; 2019; 19(7):534-550. PubMed ID: 30360743 [TBL] [Abstract][Full Text] [Related]
2. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy. Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL J Cell Physiol; 2018 Jan; 234(1):348-368. PubMed ID: 30069931 [TBL] [Abstract][Full Text] [Related]
3. Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma. Wang G; Fu XL; Wang JJ; Guan R; Tang XJ Curr Cancer Drug Targets; 2017; 17(1):17-39. PubMed ID: 27562399 [TBL] [Abstract][Full Text] [Related]
4. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies. El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217 [TBL] [Abstract][Full Text] [Related]
5. Targeting cancer stem-like cells in glioblastoma and colorectal cancer through metabolic pathways. Kahlert UD; Mooney SM; Natsumeda M; Steiger HJ; Maciaczyk J Int J Cancer; 2017 Jan; 140(1):10-22. PubMed ID: 27389307 [TBL] [Abstract][Full Text] [Related]
6. Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy. Masci D; Puxeddu M; Silvestri R; La Regina G Molecules; 2024 May; 29(9):. PubMed ID: 38731601 [TBL] [Abstract][Full Text] [Related]
7. Strategies to target energy metabolism in consensus molecular subtype 3 along with Kirsten rat sarcoma viral oncogene homolog mutations for colorectal cancer therapy. Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL J Cell Physiol; 2019 May; 234(5):5601-5612. PubMed ID: 30341899 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis Mill. Wang G; Wang YZ; Yu Y; Wang JJ J Ethnopharmacol; 2019 May; 235():255-267. PubMed ID: 30772482 [TBL] [Abstract][Full Text] [Related]
9. The Anti-Tumor Effect and Mechanism of Triterpenoids in Wang G; Wang YZ; Yu Y; Yin PH; Xu K; Zhang H Integr Cancer Ther; 2021; 20():15347354211017219. PubMed ID: 34014135 [No Abstract] [Full Text] [Related]
10. Targeting T cell metabolism in the tumor microenvironment: an anti-cancer therapeutic strategy. Yin Z; Bai L; Li W; Zeng T; Tian H; Cui J J Exp Clin Cancer Res; 2019 Sep; 38(1):403. PubMed ID: 31519198 [TBL] [Abstract][Full Text] [Related]
11. Targeting the Warburg effect in hematological malignancies: from PET to therapy. Shanmugam M; McBrayer SK; Rosen ST Curr Opin Oncol; 2009 Nov; 21(6):531-6. PubMed ID: 19587591 [TBL] [Abstract][Full Text] [Related]
12. [Metabolic Competition in Tumor Microenvironment]. Eikawa S; Udono H Gan To Kagaku Ryoho; 2017 Nov; 44(11):972-976. PubMed ID: 29138369 [TBL] [Abstract][Full Text] [Related]
13. Tumor aerobic glycolysis: new insights into therapeutic strategies with targeted delivery. Talekar M; Boreddy SR; Singh A; Amiji M Expert Opin Biol Ther; 2014 Aug; 14(8):1145-59. PubMed ID: 24762115 [TBL] [Abstract][Full Text] [Related]
14. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy. Amoedo ND; Obre E; Rossignol R Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330 [TBL] [Abstract][Full Text] [Related]
15. DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway. Wei X; Mao T; Li S; He J; Hou X; Li H; Zhan M; Yang X; Li R; Xiao J; Yuan S; Sun L Phytomedicine; 2019 Feb; 54():120-131. PubMed ID: 30668361 [TBL] [Abstract][Full Text] [Related]
16. Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin. Bahrambeigi S; Shafiei-Irannejad V Biochem Pharmacol; 2020 Apr; 174():113787. PubMed ID: 31884044 [TBL] [Abstract][Full Text] [Related]
17. Peiminine inhibits colorectal cancer cell proliferation by inducing apoptosis and autophagy and modulating key metabolic pathways. Zheng Z; Xu L; Zhang S; Li W; Tou F; He Q; Rao J; Shen Q Oncotarget; 2017 Jul; 8(29):47619-47631. PubMed ID: 28496003 [TBL] [Abstract][Full Text] [Related]
18. Metabolic targeting of malignant tumors: small-molecule inhibitors of bioenergetic flux. Mathupala SP Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):6-14. PubMed ID: 21110820 [TBL] [Abstract][Full Text] [Related]
19. p53 and glucose metabolism: an orchestra to be directed in cancer therapy. Gomes AS; Ramos H; Soares J; Saraiva L Pharmacol Res; 2018 May; 131():75-86. PubMed ID: 29580896 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of tumor energy pathways for targeted esophagus cancer therapy. Shafaee A; Dastyar DZ; Islamian JP; Hatamian M Metabolism; 2015 Oct; 64(10):1193-8. PubMed ID: 26271140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]